Azithromycin in the treatment of children with chronic airway disease (CAD) Source: Eur Respir J 2003; 22: Suppl. 45, 143s Year: 2003
Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
Systemic inflammation in patients with COPD and anemia of chronic disease Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Walking strategy in severe chronic lung disease (CLD) patients Source: Eur Respir J 2005; 26: Suppl. 49, 309s Year: 2005
Chronic interstitial lung disease in children: diagnosis and treatment Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis Year: 2016
Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Chloroquine treatment of interstitial lung diseases in children Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
The effect of 3 months oral clarithromycin on sputum bacterial colonization in stable moderate- to- severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007
Clinical evaluation of a new inhibitor of neutrophilic inflammation, tetomilast (OPC-6535), in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 527s Year: 2006
Pulmonary involvement of inflammatory bowel disease in children and adult patients Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007